📊 PAXH Key Takeaways
Is Preaxia Health Care Payment Systems Inc.. (PAXH) a Good Investment?
PAXH is a non-operating company with zero revenue, ongoing operating losses of $875K, and negative free cash flow of $74.8K. With a current ratio of 0.68x and only $130.3K in cash reserves against a burn rate of approximately $75K per quarter, the company faces imminent liquidity constraints and likely insolvency without significant operational turnaround or external capital.
Why Buy Preaxia Health Care Payment Systems Inc.. Stock? PAXH Key Strengths
- Minimal debt burden (Debt/Equity: 0.00x) reduces refinancing risk
- Some residual cash reserves of $130.3K provide temporary runway
- Total liabilities ($723K) are manageable relative to total assets ($1.2M)
PAXH Stock Risks: Preaxia Health Care Payment Systems Inc.. Investment Risks
- Zero revenue indicates complete absence of operating business or commercial traction
- Negative operating cash flow of $74.8K per period indicates unsustainable cash burn
- Current ratio of 0.68x signals acute liquidity crisis and inability to meet short-term obligations
- Limited cash runway of approximately 1.7 quarters at current burn rate
- Negative ROE of -204.8% and ROA of -76.1% demonstrate capital destruction
- Zero insider transactions in 90 days suggests no management confidence in turnaround
- Sector classification mismatch (health care payments vs home furniture) indicates possible data quality or business model issues
Key Metrics to Watch
- Revenue generation and return to positive sales
- Operating cash flow trajectory and burn rate deceleration
- Cash balance depletion rate relative to operating losses
- Current ratio improvement above 1.0 threshold
- Insider Form 4 transactions indicating management confidence
Preaxia Health Care Payment Systems Inc.. (PAXH) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
PAXH Profit Margin, ROE & Profitability Analysis
PAXH vs Consumer Sector: How Preaxia Health Care Payment Systems Inc.. Compares
How Preaxia Health Care Payment Systems Inc.. compares to Consumer sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Preaxia Health Care Payment Systems Inc.. Stock Overvalued? PAXH Valuation Analysis 2026
Based on fundamental analysis, Preaxia Health Care Payment Systems Inc.. has mixed fundamental signals relative to the Consumer sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Preaxia Health Care Payment Systems Inc.. Balance Sheet: PAXH Debt, Cash & Liquidity
PAXH Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Preaxia Health Care Payment Systems Inc..'s revenue has declined by 100% over the 5-year period, indicating business contraction. The most recent EPS of $-0.01 indicates the company is currently unprofitable.
PAXH Revenue Growth, EPS Growth & YoY Performance
PAXH Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | N/A | -$4.6K | $0.00 |
| Q3 2025 | N/A | -$8.8K | $0.00 |
| Q2 2025 | N/A | -$13.7K | $0.00 |
| Q1 2025 | N/A | -$4.6K | $0.00 |
| Q3 2024 | N/A | -$8.8K | $0.00 |
| Q2 2024 | N/A | -$45.1K | $0.00 |
| Q1 2024 | N/A | -$37.3K | $0.00 |
| Q3 2023 | N/A | -$36.5K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Preaxia Health Care Payment Systems Inc.. Dividends, Buybacks & Capital Allocation
PAXH SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Preaxia Health Care Payment Systems Inc.. (CIK: 0001350156)
📋 Recent SEC Filings
❓ Frequently Asked Questions about PAXH
What is the AI rating for PAXH?
Preaxia Health Care Payment Systems Inc.. (PAXH) has an AI rating of STRONG SELL with 98% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PAXH's key strengths?
Claude: Minimal debt burden (Debt/Equity: 0.00x) reduces refinancing risk. Some residual cash reserves of $130.3K provide temporary runway.
What are the risks of investing in PAXH?
Claude: Zero revenue indicates complete absence of operating business or commercial traction. Negative operating cash flow of $74.8K per period indicates unsustainable cash burn.
What is PAXH's revenue and growth?
Preaxia Health Care Payment Systems Inc.. reported revenue of $0.0.
Does PAXH pay dividends?
Preaxia Health Care Payment Systems Inc.. does not currently pay dividends.
Where can I find PAXH SEC filings?
Official SEC filings for Preaxia Health Care Payment Systems Inc.. (CIK: 0001350156) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PAXH's EPS?
Preaxia Health Care Payment Systems Inc.. has a diluted EPS of $-0.04.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is PAXH a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Preaxia Health Care Payment Systems Inc.. has a STRONG SELL rating with 98% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is PAXH stock overvalued or undervalued?
Valuation metrics for PAXH: ROE of -204.8% (sector avg: 18%), net margin of N/A (sector avg: 8%). Compare these metrics with sector averages to assess valuation.
Should I buy PAXH stock in 2026?
Our dual AI analysis gives Preaxia Health Care Payment Systems Inc.. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PAXH's free cash flow?
Preaxia Health Care Payment Systems Inc..'s operating cash flow is $-74.8K, with capital expenditures of N/A.
How does PAXH compare to other Consumer stocks?
Vs Consumer sector averages: Net margin N/A (avg: 8%), ROE -204.8% (avg: 18%), current ratio 0.68 (avg: 1.5).